Arecor Therapeutics plc (LON:AREC – Get Free Report) shares reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 72.02 ($0.95) and last traded at GBX 72.03 ($0.95), with a volume of 16609 shares traded. The stock had previously closed at GBX 80 ($1.06).
Arecor Therapeutics Trading Down 10.0 %
The firm has a 50-day moving average of GBX 90.12 and a 200-day moving average of GBX 120.37. The company has a debt-to-equity ratio of 3.55, a quick ratio of 6.24 and a current ratio of 2.17. The firm has a market capitalization of £27.20 million, a P/E ratio of -285.71 and a beta of -0.17.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Further Reading
- Five stocks we like better than Arecor Therapeutics
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- How to Capture the Benefits of Dividend Increases
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- How to invest in marijuana stocks in 7 steps
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
